Valuation
- Market cap
- 500,609,000
- Revenue TTM
- $329,520,000
- Net income TTM
- $19,090,000
- PE ratio
- 20.10
- Forward PE
- 19.83
- Profit margin
- 5.79%
- Debt to equity
- 0.00
Trading
- Volume
- 252,300
- Avg volume
- 316,566
- Day's range
- $21.61 – $22.43
- Shares out
- 22,652,000
- Stochastic %K
- 29%
- Beta
- 0.82
- Analysts
- Strong Sell
- Price target
- $39.00
Company profile
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home t...
Show more
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 612 355 5100
- Website
- https://tactilemedical.com
- Address
- 3701 Wayzata Boulevard, Suite 300, Minneapolis, United States
Latest news
No headlines yet.